📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief Report. (2017)

First Author: Verbeek R

Attributed to: The EPIC-Norfolk prospective population study: biological and behavioural determinants of health and disease in an ageing population funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/atvbaha.116.307995

PubMed Identifier: 27856457

Publication URI: http://europepmc.org/abstract/MED/27856457

Type: Journal Article/Review

Volume: 37

Parent Publication: Arteriosclerosis, thrombosis, and vascular biology

Issue: 1

ISSN: 1079-5642